EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nitrous Oxide Sourcing, Use and Harms: Insights From Australians Who Use Ecstasy/MDMA and Other Illicit Stimulants

Jodie Grigg iD, Simon Lenton iD, Amy Peacock iD, Jessamine Soderstrom iD, Cate King, Natalie Thomas iD, Rachel Sutherland iD

Drug and Alcohol Review · 2025

DOI: 10.1111/dar.70032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug and Alcohol Review, 2025. Verfasst von Jodie Grigg und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Drug Research Institute and enAble Institute, Curtin University, Perth, Australia. Hauptthemen laut MEDLINE: Nitrous Oxide, N-Methyl-3,4-methylenedioxyamphetamine, Illicit Drugs, Substance-Related Disorders. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Australian Government Department of Health and Aged Care, Drug Trends program (including the Ecstasy and Related Drugs Reporting System).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Increasing harms associated with nitrous oxide use have raised concerns, but limited evidence exists to inform harm reduction. This study aimed to identify how nitrous oxide is sourced, the products/forms used, awareness of health risks, engagement in harm reduction and experience of neurological symptoms.

Methods

Data were collected via annual interviews (2021–2023) with cross‐sectional convenience samples of Australians who regularly used ecstasy/MDMA and/or other illicit stimulants and reported past 6‐month use of nitrous oxide (2021 n = 379; 2022 n = 315; 2023 n = 284).

Results

The most commonly reported source of nitrous oxide in the past 6 months was convenience stores, followed by 24/7 delivery services. Sourcing from these retailers was also associated with heavier use. Reported use of larger cylinders (> 8 g) increased from 6% in 2021 to 26% in 2023. While most respondents demonstrated awareness of neurological risk (e.g., brain damage 63%; nerve damage 20%), only one‐fifth identified the risk of Vitamin B12 depletion and 17% were unaware of any risks. Almost one‐third (30%) reported limiting use per session, 36% limited frequency and 36% took no precautions. Reports of neurological symptoms rose from 5% in 2021 to 14% in 2023 among cross‐sectional samples, with few ( n ≤ 5) receiving treatment. Discussion and Conclusions Findings suggest increasing use of larger cylinders, alongside increasing neurological harms. Given the evolving regulatory and risk environment, close surveillance of usage and market trends is needed. The findings reinforce the need for balanced regulation and targeted education of retailers, clinicians and consumers to reduce harmful patterns of use and encourage early intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitrous OxideN-Methyl-3,4-methylenedioxyamphetamineIllicit DrugsSubstance-Related DisordersCentral Nervous System StimulantsHumansAustraliaCross-Sectional StudiesMaleAdultFemaleYoung AdultHarm ReductionMiddle AgedAdolescentAustralasian People

Stichwörter der Autor:innen

Vitamin B12 deficiencydrug monitoringharm reductionneurologic symptomsnitrous oxide

Substanzen

Nitrous OxideN-Methyl-3,4-methylenedioxyamphetamineIllicit DrugsCentral Nervous System Stimulants

Autor:innen und Institutionen

  • National Drug Research Institute and enAble Institute, Curtin University, Perth, Australia.
  • National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
  • School of Psychological Sciences, University of Tasmania, Hobart, Australia.
  • Emergency Department, Royal Perth Hospital, Perth, Australia.
  • Institute for Social Science Research, University of Queensland, Brisbane, Australia.

ORCID-Profile: Jodie Grigg, Simon Lenton, Amy Peacock, Jessamine Soderstrom, Natalie Thomas, Rachel Sutherland

Förderung

  • National Health and Medical Research Council
  • Australian Government Department of Health and Aged Care
  • Drug Trends program (including the Ecstasy and Related Drugs Reporting System)
  • National Drug and Alcohol Research Centre
  • National Drug Research Institute
  • Department of Health and Aged Care, Australian Government

Zitieren

APA

Grigg, J., Lenton, S., Peacock, A., Soderstrom, J., King, C., Thomas, N., & Sutherland, R. (2025). Nitrous Oxide Sourcing, Use and Harms: Insights From Australians Who Use Ecstasy/MDMA and Other Illicit Stimulants. Drug and Alcohol Review. https://doi.org/10.1111/dar.70032

Vancouver

Grigg J, Lenton S, Peacock A, Soderstrom J, King C, Thomas N, et al. Nitrous Oxide Sourcing, Use and Harms: Insights From Australians Who Use Ecstasy/MDMA and Other Illicit Stimulants. Drug and Alcohol Review. 2025. doi:10.1111/dar.70032

BibTeX
@article{Grigg2025,
  author = {Grigg, Jodie and Lenton, Simon and Peacock, Amy and Soderstrom, Jessamine and King, Cate and Thomas, Natalie and Sutherland, Rachel},
  title = {Nitrous Oxide Sourcing, Use and Harms: Insights From Australians Who Use Ecstasy/MDMA and Other Illicit Stimulants},
  journal = {Drug and Alcohol Review},
  year = {2025},
  doi = {10.1111/dar.70032}
}
Kostenlos starten →